Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: An antibody–supermolecule conjugate for tumor-specific targeting of tumoricidal methylated β-cyclodextrin-threaded polyrotaxanes
Kei
Nishida
a,
Atsushi
Tamura
*a,
Tae Woong
Kang
a,
Hiroki
Masuda
b and
Nobuhiko
Yui
a
aDepartment of Organic Biomaterials, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Chiyoda, 2-3-10 Kanda-Surugadai, Tokyo 101-0062, Japan. E-mail: tamura.org@tmd.ac.jp; Tel: +81-3-5280-8022
bDepartment of Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Bunkyo, 1-5-45 Yushima, Tokyo 113-8549, Japan
First published on 30th July 2020
Abstract
Correction for ‘An antibody–supermolecule conjugate for tumor-specific targeting of tumoricidal methylated β-cyclodextrin-threaded polyrotaxanes’ by Kei Nishida et al., J. Mater. Chem. B, 2020, DOI: 10.1039/d0tb00575d.
In the original manuscript, an author's name was spelled incorrectly. The correct spelling is “Atsushi Tamura”, as shown above.
In the original manuscript, the units used in the figure caption for Fig. 7C were incorrect. Fig. 7C and its corrected caption are shown below.
 | ||
| Fig. 7 Viability of BT-474 cells treated with Tras-Me-PRX (500 μg mL−1 antibody, 13.5 mM Me-PRX) in the presence of 3-MA (10 mM) for 48 h. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2020 |